Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20093
20101
20111
20141
20151
20171
20182
20193
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pharming Technologies B.V.4
Novo Nordisk A/S3
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Editas Medicine, Inc.1
Erasmus Medical Center1
Kastle Therapeutics, LLC1
Leiden University Medical Center1
NewAmsterdam Pharma1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn21
Metabolic Diseases4
Congenital Abnormalities3
Infant, Newborn, Diseases3
Lipid Metabolism Disorders3
Lipid Metabolism, Inborn Errors3
Metabolism, Inborn Errors3
Angioedemas, Hereditary2
Cystic Fibrosis2
Digestive System Diseases2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.